Holen Sie sich die Stockscreener-App
4.16
0.95%
-0.04
Vorhandelsmarkt:
4.44
0.28
+6.73%
Schlusskurs vom Vortag:
$4.20
Offen:
$4.1801
24-Stunden-Volumen:
60,450
Relative Volume:
0.48
Marktkapitalisierung:
$26.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.7854
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
-1.19%
1M Leistung:
+1.46%
6M Leistung:
+199.28%
1J Leistung:
+108.00%
1-Tages-Spanne:
$4.055
$4.30
1-Wochen-Bereich:
$3.9283
$4.80
52-Wochen-Spanne:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
433 PLAZA REAL, BOCA RATON
Vergleichen Sie LIXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.16 | 26.34M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy on weaknessWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
What sentiment indicators say about Lixte Biotechnology Holdings Inc. stockJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser
Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued historicallyQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser
Can Lixte Biotechnology Holdings Inc. stock deliver consistent earnings growthJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Published on: 2025-12-04 00:03:12 - Newser
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Yahoo Finance
LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers - Yahoo Finance
Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Will Lixte Biotechnology Holdings Inc. stock maintain momentum in 2025Weekly Trade Review & Verified Short-Term Plans - Newser
There is no doubt that Lixte Biotechnology Holdings Inc (LIXT) ticks all the boxes. - Setenews
Lixte Biotechnology Acquires Liora Technologies for Growth - TipRanks
Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN
LIXTE Biotechnology acquires UK-based proton therapy developer Liora By Investing.com - Investing.com Nigeria
Lixte Biotechnology stock falls after acquiring UK-based Liora By Investing.com - Investing.com Canada
Lixte Biotechnology stock falls after acquiring UK-based Liora - Investing.com
LIXTE Biotechnology (LIXT) Expands with Acquisition of Liora Tec - GuruFocus
LIXTE Biotechnology acquires UK-based proton therapy developer Liora - Investing.com India
LIXTE Biotechnology Holdings, Inc. Completes Acquisition of Liora Technologies Europe Ltd. to Advance Proton Therapy Treatment for Cancer - Quiver Quantitative
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment - InvestorNews
LIXTE (Nasdaq: LIXT) acquires Liora LiGHT proton therapy platform with $300M+ backing - Stock Titan
S&P 500, Dow and NASDAQ end day on positive note as Wall Street begins Thanksgiving week on high with boos - The Economic Times
Lixte Biotechnology announces $5M equity financing; shares down - MSN
Will Upside Catalysts Materialize for Vallabh Steels Limited in YEARGrowth Stock Opportunities & Small Capital Investment Tips - earlytimes.in
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants By Investing.com - Investing.com Australia
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants - Investing.com UK
Lixte Biotechnology Holdings Inc. (LIXT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Key Metrics Every Investor Should Know About Shree Hari Chemicals Export Limited - earlytimes.in
Will Lixte Biotechnology Holdings Inc. Equity Warrant stock benefit from automation - newser.com
Can Lixte Biotechnology Holdings Inc. stock maintain growth trajectory2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock positioned well for digital economy2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock sustain market leadership2025 Top Gainers & Free Weekly Watchlist of Top Performers - newser.com
Will Lixte Biotechnology Holdings Inc. stock attract ESG investorsTake Profit & Growth Focused Stock Pick Reports - newser.com
Will Lixte Biotechnology Holdings Inc. (8640) stock hit analyst forecasts2025 Macro Impact & Safe Entry Momentum Stock Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock a safe buy before earnings2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy during volatile marketsJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock resilient to inflation2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant trending in predictive chart modelsJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - newser.com
Market reaction to Lixte Biotechnology Holdings Inc.’s recent news - newser.com
How risky is Lixte Biotechnology Holdings Inc. Equity Warrant stock now2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
How Lixte Biotechnology Holdings Inc. Equity Warrant stock compares to market leadersJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
What technical charts say about Lixte Biotechnology Holdings Inc. Equity Warrant stockQuarterly Profit Summary & Real-Time Stock Movement Alerts - newser.com
How to use a screener to detect Lixte Biotechnology Holdings Inc. breakoutsTake Profit & Verified Entry Point Signals - newser.com
Will Lixte Biotechnology Holdings (NASDAQ:LIXT) Spend Its Cash Wisely? - Yahoo Finance
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):